<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05092672</url>
  </required_header>
  <id_info>
    <org_study_id>H21-01487</org_study_id>
    <nct_id>NCT05092672</nct_id>
  </id_info>
  <brief_title>Physical Activity, Air Pollution, and High Blood Pressure</brief_title>
  <official_title>Impact of Traffic-related Air Pollution on the Cardiovascular and Pulmonary Response to Physical Activity in Patients With Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of British Columbia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators are investigating the effects of traffic-related air pollution (TRAP) on&#xD;
      the cardiovascular and pulmonary response to exercise in patients with hypertension using a&#xD;
      real world randomized, crossover study design. Participants will be exposed to 2 conditions:&#xD;
      a low TRAP environment and a high TRAP environment. Each exposure will consist of 30 min of&#xD;
      moderate-intensity exercise. Cardiovascular and pulmonary health outcomes will be measured&#xD;
      before, during, and up to 24 hours following exposures. A minimum washout period of 1 week&#xD;
      will be used to minimize carryover effects.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 2021</start_date>
  <completion_date type="Anticipated">October 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Crossover Assignment</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from Baseline Blood Pressure at 2 Hours Post-Exposure</measure>
    <time_frame>Baseline and 2 hours post-exposure</time_frame>
    <description>MAP, SBP, and DBP</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>24-Hour Blood Pressure</measure>
    <time_frame>24 hours post-exposure</time_frame>
    <description>MAP, SBP, and DBP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart Rate Variability</measure>
    <time_frame>Baseline and up to 24 hours post-exposure</time_frame>
    <description>Indices of heart rate variability</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Arterial Stiffness at 2 Hours Post-Exposure</measure>
    <time_frame>Baseline and 2 hours post-exposure</time_frame>
    <description>Pulse wave velocity and augmentation index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Microvascular Responsiveness at 2 Hours Post-Exposure</measure>
    <time_frame>Baseline and 2 hours post-exposure</time_frame>
    <description>Microvascular responsiveness (measured by near-infrared spectroscopy)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle Oxygen Saturation</measure>
    <time_frame>Continuously throughout the 30 minute exercise bouts (during exposure)</time_frame>
    <description>Muscle oxygen saturation (measured by near-infrared spectroscopy)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline FEV1 and FVC at 2 Hours Post-Exposure</measure>
    <time_frame>Baseline and 2 hours post-exposure</time_frame>
    <description>Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) measured by spirometry (in L)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline FEV1/FVC at 2 Hours Post-Exposure</measure>
    <time_frame>Baseline and 2 hours post-exposure</time_frame>
    <description>FEV1/FVC ratio measured by spirometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline FEF25-75 and PEFR at 2 Hours Post-Exposure</measure>
    <time_frame>Baseline and 2 hours post-exposure</time_frame>
    <description>Forced expiratory flow at 25-75% of forced vital capacity (FEF25-75) and peak expiratory flow rate (PEFR) measured by spirometry (in L/s)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severity of Symptoms</measure>
    <time_frame>Baseline and 2 hours post-exposure</time_frame>
    <description>Severity of respiratory symptoms (e.g., dyspnea, cough, wheeze, chest tightness) and headache on a 0-5 scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Essential Hypertension</condition>
  <arm_group>
    <arm_group_label>High traffic-related air pollution first</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will exercise in an environment with high levels of traffic-related air pollution first. Afterwards, participants will complete the same exercise in an environment with low levels of traffic-related air pollution.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low traffic-related air pollution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will exercise in an environment with low levels of traffic-related air pollution first. Afterwards, participants will complete the same exercise in an environment with high levels of traffic-related air pollution.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Participants will engage in moderate-intensity (40-59% HRR) exercise for 30 min</description>
    <arm_group_label>High traffic-related air pollution first</arm_group_label>
    <arm_group_label>Low traffic-related air pollution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age between 40-70 years of age&#xD;
&#xD;
          2. Previously diagnosed with elevated blood pressure or hypertension by a physician&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Current or ex-smokers (abstinent for less than one year)&#xD;
&#xD;
          2. Lives with an individual who currently smokes cigarettes, e-cigarettes (i.e., vaping),&#xD;
             or cannabis&#xD;
&#xD;
          3. Hormone replacement therapy use&#xD;
&#xD;
          4. Currently on beta-blocker or angiotensin receptor blocker (ARB) therapy&#xD;
&#xD;
          5. Currently using over the counter drugs or supplements that may alter cardiovascular&#xD;
             measures (as per the principal investigator's discretion)&#xD;
&#xD;
          6. Prior diagnosis of any other existing cardiovascular or pulmonary diseases and/or&#xD;
             conditions (other than hypertension)&#xD;
&#xD;
          7. Musculoskeletal injury or lower limb limitation preventing safe engagement in&#xD;
             moderate-intensity exercise&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Koehle, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andy Hung, BKin</last_name>
    <phone>(604) 822-6833</phone>
    <email>kin.epl@ubc.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of British Columbia</name>
      <address>
        <city>Vancouver</city>
        <state>British Columbia</state>
        <zip>V6T 1Z3</zip>
        <country>Canada</country>
      </address>
    </facility>
    <contact>
      <last_name>Michael Koehle, MD, PhD</last_name>
      <phone>(604) 822-6833</phone>
      <email>michael.koehle@ubc.ca</email>
    </contact>
    <investigator>
      <last_name>Michael Koehle, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 28, 2021</study_first_submitted>
  <study_first_submitted_qc>October 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2021</study_first_posted>
  <last_update_submitted>October 21, 2021</last_update_submitted>
  <last_update_submitted_qc>October 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of British Columbia</investigator_affiliation>
    <investigator_full_name>Michael Koehle</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Traffic-related air pollution</keyword>
  <keyword>Physical activity</keyword>
  <keyword>Exercise</keyword>
  <keyword>Blood pressure</keyword>
  <keyword>Heart rate variability</keyword>
  <keyword>Arterial stiffness</keyword>
  <keyword>Microvascular responsiveness</keyword>
  <keyword>Muscle oxygen saturation</keyword>
  <keyword>Lung function</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Essential Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

